Triple

T11074793
Position Surface form Disambiguated ID Type / Status
Subject APHINITY trial E261835 entity
Predicate fullName P16 FINISHED
Object Adjuvant Pertuzumab and Herceptin IN Initial TherapY trial E261835 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Adjuvant Pertuzumab and Herceptin IN Initial TherapY trial | Statement: [APHINITY trial, fullName, Adjuvant Pertuzumab and Herceptin IN Initial TherapY trial]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Adjuvant Pertuzumab and Herceptin IN Initial TherapY trial
Context triple: [APHINITY trial, fullName, Adjuvant Pertuzumab and Herceptin IN Initial TherapY trial]
  • A. pertuzumab
    Pertuzumab is a monoclonal antibody used in targeted therapy for HER2-positive breast cancer, often administered alongside trastuzumab and chemotherapy.
  • B. Ibrance
    Ibrance is a targeted oral cancer medication (palbociclib) used primarily to treat certain types of hormone receptor–positive, HER2-negative advanced or metastatic breast cancer.
  • C. Herceptin
    Herceptin is a targeted monoclonal antibody drug used primarily to treat HER2-positive breast cancer by blocking the HER2 receptor on cancer cells.
  • D. APHINITY trial chosen
    The APHINITY trial is a large phase III clinical study that evaluated the addition of pertuzumab (Perjeta) to standard trastuzumab-based adjuvant therapy in patients with HER2-positive early breast cancer.
  • E. INA trials
    INA trials were a series of high-profile court-martials held by the British colonial government in 1945–46 to prosecute officers and soldiers of Subhas Chandra Bose’s Indian National Army, which became a major catalyst for India’s independence movement.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d6aa9983c08190b0ef61603b69feac completed April 8, 2026, 7:20 p.m.
NER Named-entity recognition batch_69d7994efb608190a81bc8c4d16ddbd0 completed April 9, 2026, 12:19 p.m.
NED1 Entity disambiguation (via context triple) batch_69e3c8cc77988190aad54f56dbd0f8cf completed April 18, 2026, 6:09 p.m.
Created at: April 8, 2026, 9:26 p.m.